...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

Hey Narmac

 

i agree 100% with your statements 

Anyone want to forward to the both Don McCaffrey and the BOD all the Biotech IPO and deals you linked to say what bullshit that the market right now is so difficult to get a BP deal

 

 

 

Share
New Message
Please login to post a reply